Your browser doesn't support javascript.
loading
Noninvasive imaging of in vivo MuRF1 expression during muscle atrophy.
Li, Wei; Claypool, Mark D; Friera, Annabelle M; McLaughlin, John; Baltgalvis, Kristen A; Smith, Ira J; Kinoshita, Taisei; White, Kathy; Lang, Wayne; Godinez, Guillermo; Payan, Donald G; Kinsella, Todd M.
Afiliação
  • Li W; Discovery Research, Rigel Pharmaceuticals Inc., South San Francisco, California, United States of America.
  • Claypool MD; Discovery Research, Rigel Pharmaceuticals Inc., South San Francisco, California, United States of America.
  • Friera AM; Discovery Research, Rigel Pharmaceuticals Inc., South San Francisco, California, United States of America.
  • McLaughlin J; Discovery Research, Rigel Pharmaceuticals Inc., South San Francisco, California, United States of America.
  • Baltgalvis KA; Discovery Research, Rigel Pharmaceuticals Inc., South San Francisco, California, United States of America.
  • Smith IJ; Discovery Research, Rigel Pharmaceuticals Inc., South San Francisco, California, United States of America.
  • Kinoshita T; Discovery Research, Rigel Pharmaceuticals Inc., South San Francisco, California, United States of America.
  • White K; Discovery Research, Rigel Pharmaceuticals Inc., South San Francisco, California, United States of America.
  • Lang W; Discovery Research, Rigel Pharmaceuticals Inc., South San Francisco, California, United States of America.
  • Godinez G; Discovery Research, Rigel Pharmaceuticals Inc., South San Francisco, California, United States of America.
  • Payan DG; Discovery Research, Rigel Pharmaceuticals Inc., South San Francisco, California, United States of America.
  • Kinsella TM; Discovery Research, Rigel Pharmaceuticals Inc., South San Francisco, California, United States of America.
PLoS One ; 9(4): e94032, 2014.
Article em En | MEDLINE | ID: mdl-24710205
ABSTRACT
Numerous human diseases can lead to atrophy of skeletal muscle, and loss of this tissue has been correlated with increased mortality and morbidity rates. Clinically addressing muscle atrophy remains an unmet medical need, and the development of preclinical tools to assist drug discovery and basic research in this effort is important for advancing this goal. In this report, we describe the development of a bioluminescent gene reporter rat, based on the zinc finger nuclease-targeted insertion of a bicistronic luciferase reporter into the 3' untranslated region of a muscle specific E3 ubiquitin ligase gene, MuRF1 (Trim63). In longitudinal studies, we noninvasively assess atrophy-related expression of this reporter in three distinct models of muscle loss (sciatic denervation, hindlimb unloading and dexamethasone-treatment) and show that these animals are capable of generating refined detail on in vivo MuRF1 expression with high temporal and anatomical resolution.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atrofia Muscular / Músculo Esquelético / Ubiquitina-Proteína Ligases / Medições Luminescentes / Proteínas Musculares Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atrofia Muscular / Músculo Esquelético / Ubiquitina-Proteína Ligases / Medições Luminescentes / Proteínas Musculares Idioma: En Ano de publicação: 2014 Tipo de documento: Article